Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07520110) titled 'Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis' on April 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: University of Massachusetts, Worcester

Condition: Idiopathic Pulmonary Fibrosis

Intervention: Drug: Metformin

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: August 1, 2026

Target Sample Size: 800

Countries of Recruitment: United States

To know ...